Luca Antonio Aldrighetti
Luca Antonio Aldrighetti publishes mostly in Surgery, Hepatology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies and Gallbladder and Bile Duct Disorders.
- World rank
- #102,003 of 7,710,434 ranked researchers
- Rank in Italy
- #1,957 of 242,206
- Works
- 988
- Citations
- 28k
- Citations per work
- 28.5
What does Luca Antonio Aldrighetti research?
Luca Antonio Aldrighetti's work is mostly in Medicine (87%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences86287.2%
- Medicine86287.2%
- Everything else11111.2%
- Life Sciences161.6%
- 1Surgery29% of their works
- 2Hepatology25% of their works
- 3Pulmonary and Respiratory Medicine14% of their works
- 4Oncology14% of their works
- 5Epidemiology6% of their works
- 6Cancer Research2% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Gallbladder and Bile Duct Disorders
- Pancreatic and Hepatic Oncology Research
- Organ Transplantation Techniques and Outcomes
- Liver Disease Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
- Liver Disease and Transplantation
Which keywords describe Luca Antonio Aldrighetti's research?
The keywords of their largest research topics: Hepatocellular Carcinoma, Clinical Practice Guidelines, Cholangiocarcinoma, Liver Cancer, Management, Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma and Chemotherapy.
- Liver Cirrhosis
- Gastric Cancer
- NASH
- Liver Transplantation
- Surgical Complications
- ERCP
- Chemotherapy
- Biliary Tract Cancer
- Liver Cancer
- Clinical Practice Guidelines
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Management
- Intrahepatic Cholangiocarcinoma
- Cholecystitis
- Pancreatic Cancer
- Ischemia-Reperfusion Injury
- NAFLD
- Endoscopic Resection
- Hepatic Encephalopathy
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Hepatocellular Carcinoma6752 topics
- Clinical Practice Guidelines6582 topics
- Cholangiocarcinoma6412 topics
- Liver Cancer5761 topic
- Management5761 topic
- Biliary Tract Cancer4071 topic
- Intrahepatic Cholangiocarcinoma4071 topic
- Chemotherapy2512 topics
- Cholecystitis2341 topic
- ERCP2341 topic
- Pancreatic Cancer1691 topic
- Surgical Complications1691 topic
- Ischemia-Reperfusion Injury1671 topic
- Liver Transplantation1671 topic
- NAFLD991 topic
- NASH991 topic
- Endoscopic Resection821 topic
- Gastric Cancer821 topic
- Hepatic Encephalopathy761 topic
- Liver Cirrhosis761 topic
Where does Luca Antonio Aldrighetti work?
Luca Antonio Aldrighetti's main affiliation in the publication record is Vita-Salute San Raffaele University, Italy.
How many publications and citations does Luca Antonio Aldrighetti have?
OpenAlex counts 988 works and 28,195 citations for Luca Antonio Aldrighetti, an h-index of 84, ranking #102,003 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Luca Antonio Aldrighetti. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.